February 21, 2018 10:06 AM ESTUpdated 02:02 PM
Startups

Se­nior R&D ex­ec Sue Dil­lon jumps ship at J&J, launch­es mys­tery biotech start­up Aro with Cen­tyrins tech

Brittany Meiling

Two for­mer ex­ec­u­tive heavy­weights at John­son & John­son have left the phar­ma gi­ant to launch a rather stealthy start­up called Aro Bio­ther­a­peu­tics – and they …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times